5Kim H,Yun M,Kwon KI.Pharmacokinetic and pharmacodynamic characterization of gliclazide in healthy volunteers[J].Arch Pharm Res,2003,26(7):564-572.
6Wu CZ,Pei D,Hsieh AT,et al.Comparison of insulin sensitivity,glucose sensitivity,and first phase insulin secretion in patients treated with repaglinide or gliclazide[J].Arch Pharm Res,2010,33(3):411-416.
9Wang CY,Zhang W,Xiang BR,et al.Liquid chromatography-mass spectrometry method for the determination of gliclazide in human plasma and application to a pharmacokinetic study of gliclazide sustained release tablets[J].Arzneimittelforschung,2008,58(12):658-666.
10Cho HY,Yoon H,Lim YC,et al.Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects[J].Int J Clin Pharmacol Ther,2009,47(12):770-779.
